Riskpilot← Back to searchSign inGet full accessMEDIPURE SCANDINAVIA A/S
A/SDissolvedCVR 13275149Strandvænget 5BWholesale of pharmaceutical and medical goods · NACE 4646Est. 1989— employees
Revenue 2024
DKK -25K
+50% vs 2023
EBITDA margin
287.6%
-13% vs 2023
Equity ratio
98.6%
Financial strength
Net profit 2024
DKK -4K
+25% vs 2023
| Revenue | DKK -25K | +50% |
| EBITDA | DKK -71K | -13% |
| Net profit | DKK -4K | +25% |
| Total assets | DKK 801K | +0% |
| Equity | DKK 789K | -1% |
| Employees | — | — |
Legal name
MEDIPURE SCANDINAVIA A/S
CVR number
13275149
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juni 1989
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller bestyrelsesformanden
Address
Strandvænget 5B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -182 | 225 | 73 | -16 | -25 |
| Staff expenses | -23 | -46 | -46 | -46 | -46 |
| EBITDA | -205 | 179 | 26 | -63 | -71 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -205 | 179 | 26 | -63 | -71 |
| Net financials | -36 | -6 | 20 | 57 | 67 |
| Profit before tax | -242 | 172 | 47 | -6 | -4 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -242 | 172 | 47 | -6 | -4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.201 | 774 | 809 | 803 | 801 |
| Equity | 1.180 | 752 | 799 | 793 | 789 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 | 22 | 10 | 10 | 12 |
| Total debt | 21 | 22 | 10 | 10 | 12 |
EBITDA margin
-7120900.0%
This company
15.8%
Market median
-45069087% vs market
20202024
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20202024
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20202024
Net profit margin
-425500.0%
This company
8.1%
Market median
-5253186% vs market
20202024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Former (6) | ||
PA Audit | Audit | 1995 – 1997 |
PB Management | Management | 1989 – 1990 |
| Audit | 1989 – 1990 | |
Rr | Audit | 1989 – 1993 |
| Audit | 1989 – 1990 | |
SM Management | Management | 1989 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Chairman | 1989 – 2025 | |
| Board of Directors | 2015 – 2025 | |
| Board of Directors | 2007 – 2015 | |
| Board of Directors | 1989 – 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIPURE SCANDINAVIA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| PP AF 22.11.1995 A/S | Audit | 0 companies |
| Preben Bang Henriksen | Management | 0 companies |
| REVISIONS- OG FORVATNINGS- INSTITUTET AKTIESELSKAB | Audit | 0 companies |
| Reg. revisor Ole Pedersen | Audit | 0 companies |
| Erik Vestergaard Christiansen | Audit | 0 companies |
| Susanne Munch | Management | 0 companies |
| Ole Munch | Chairman | 0 companies |
| Thomas Munch | Board of Directors | 0 companies |
| Inga Kathrine Mortensen | Board of Directors | 0 companies |
| Kai Mortensen | Board of Directors | 0 companies |